Vinbarbital

Vinbarbital
Clinical data
Routes of; administration	Oral
ATC code	N05CA09 (WHO) ;
Legal status
Legal status	CA: Schedule IV; US: Schedule III;
Identifiers
	IUPAC name 5-ethyl-5-[(1E)-1-methylbut-1-en-1-yl]pyrimidine-2,4,6(1H,3H,5H)-trione;
CAS Number	125-42-8 ;
PubChem CID	5284636;
ChemSpider	4447681 ;
UNII	7NZH2C1T6O;
KEGG	D07322 ;
ChEMBL	ChEMBL503565 ;
CompTox Dashboard (EPA)	DTXSID00859237 DTXSID1023738, DTXSID00859237 ;
ECHA InfoCard	100.004.309
Chemical and physical data
Formula	C11H16N2O3
Molar mass	224.260 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1NC(=O)NC(=O)C1(/C(=C/CC)C)CC;
	InChI InChI=1S/C11H16N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h6H,4-5H2,1-3H3,(H2,12,13,14,15,16)/b7-6+ ; Key:RAFOHKSPUDGZPR-VOTSOKGWSA-N ;
	(what is this?) (verify)

Vinbarbital is a hypnotic drug which is a barbiturate derivative.^[1] It was developed by Sharp and Dohme in 1939.^[2]

References

^ Mueller VA (March 1950). "An analysis and evaluation of vinbarbital sodium for obstetric amnesia and analgesia". American Journal of Obstetrics and Gynecology. 59 (3): 679–84. doi:10.1016/0002-9378(50)90253-5. PMID 15405833.
^ US 2187703